| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,674 | 8,241 | 8,044 | 8,051 | | Cost of Revenue | 1,160 | 2,623 | 2,433 | 7,719 | | | Gross Profit | 7,513 | 5,618 | 5,611 | 332 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,575 | 252 | 406 | (4,241) | | Non Recurring |
-
|
-
|
-
| 745 | | Others | 1,911 | 1,908 | 1,909 | 1,896 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,028 | 3,459 | 3,296 | 1,932 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,028 | 3,459 | 3,296 | 1,932 | | Interest Expense | 1,276 | 1,381 | 1,410 | 2,174 | | Income Before Tax | 1,752 | 2,077 | 1,887 | (242) | | Income Tax Expense | 606 | 709 | 648 | (82) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,146 | 1,368 | 1,238 | (160) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,146 | 1,368 | 1,238 | (160) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,146 | $1,368 | $1,238 | ($160) |
|
0.26% Nasdaq 0.00%
Income Statement
